A new study has revealed a significant reason why individuals with type 1 diabetes (T1D) have…
Pharmacology
Phase 3 study finds ziresovir significantly reduces symptoms and viral load in infants hospitalized with respiratory syncytial virus
A phase 3 study published in the New England Journal of Medicine reveals that ziresovir, an…
New research sheds light on metabolic dysfunction-associated steatotic liver disease treatment
Fatty liver disease, now more commonly referred to as metabolic dysfunction-associated steatotic liver disease (MASLD), is…
Investigational drug elinzanetant shows promise in reducing menopausal hot flashes and improving quality of life
A recent study published in the Journal of the American Medical Association (JAMA) highlights the potential…
Pharmacology Teaching program, Lecture-2: Adverse Drug Reactions by Dr. Pratibha Nadig
This lecture on “Adverse Drug Reactions” will provide an overview of the types, mechanisms, and clinical…
A new study highlights an elevated risk of severe skin reactions from commonly prescribed oral antibiotics
A recent study published in JAMA highlights the significant risks associated with commonly prescribed oral antibiotics…
Global meta-analysis confirms efficacy and safety of dengue vaccine
A recent global meta-analysis has confirmed the efficacy and safety of TAK-003, also known as Qdenga.…
Phase 3 trial shows the efficacy of benralizumab in eosinophilic esophagitis treatment
A recent phase 3 clinical trial has revealed significant findings on the efficacy and safety of…
New insights into MASH could revolutionize early diagnosis and treatment, reducing the need for liver transplants
One major contributor to the rise in liver disease is metabolic dysfunction-associated steatohepatitis (MASH), a severe…
Promising drug repurposing: tamsulosin, metoprolol, and bromocriptine as potential treatments for retinal degeneration
A team of researchers has unveiled promising results in the treatment of retinal degeneration through drug…